Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30301143 | 1.00 | CYP3A4 (0.50) | CYP3A4TRPA1ALDH1A1HPGDTDP1 | |
| SCHEMBL1045246 | 0.84 | CYP3A4 (0.59) | CYP3A4TRPA1ALDH1A1HPGDTDP1 | |
| SCHEMBL1483923 | 0.84 | CYP3A4 (0.39) | CYP3A4TRPA1ALDH1A1HPGDTDP1 | |
| SCHEMBL375132 | 0.82 | CYP3A4 (0.57) | CYP3A4TRPA1ALDH1A1HPGDTDP1 | |
| SCHEMBL1044718 | 0.82 | CYP3A4 (0.61) | CYP3A4TRPA1ALDH1A1HPGDTDP1 | |
| SCHEMBL1100599 | 0.80 | ALDH1A1 (0.49) | CYP3A4TRPA1ALDH1A1HPGDTDP1 | |
| SCHEMBL1191608 | 0.78 | CYP3A4 (0.57) | CYP3A4TRPA1ALDH1A1HPGDTDP1 | |
| SCHEMBL11618906 | 0.78 | CYP3A4 (0.38) | CYP3A4TRPA1ALDH1A1HPGDTDP1 | |
| SCHEMBL13893581 | 0.76 | CYP3A4 (0.40) | CYP3A4TRPA1 | |
| SCHEMBL78958 | 0.75 | CYP3A4 (0.50) | CYP3A4TRPA1ALDH1A1HPGDTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4791042-B2 | — | — | 2011-10-12 | — | — | JP | claimed |
| CN-1521197-B | Polycarbodiimide having high index of refraction and production method thereof | NITTO DENKO CORP | 2010-04-07 | — | — | CN | claimed |
| EP-1569512-B1 | PARTICULATE SUSPENSIONS | SYNGENTA LTD (GB) | 2007-02-28 | — | — | EP | claimed |
| US-20060116290-A1 | Particulate suspensions | SYNGENTA CROP PROTECTION, INC. | 2006-06-01 | — | — | US | claimed |
| EP-1569512-A2 | PARTICULATE SUSPENSIONS | Syngenta Limited (GB) | 2005-09-07 | — | — | EP | claimed |
| WO-2004052099-A2 | PARTICULATE SUSPENSIONS | SYNGENTA LIMITED (GB) | 2004-06-24 | — | — | WO | claimed |
| WO-2003072625-A1 | PHOTOCURABLE RESIN COMPOSITION FOR OPTICAL WAVEGUIDE AND OPTICAL WAVEGUIDE MADE OF THE SAME | LUVANTIX CO., LTD. (KR) | 2003-09-04 | — | — | WO | claimed |
| US-12227606-B2 | Photocurable resin composition, photocurable resin article, and methods of fabricating the article | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-02-18 | — | — | US | disclosed |
| CN-113260332-B | Photocurable resin composition, photocurable resin product, and method for producing product | 加利福尼亚大学董事会 | 2023-04-07 | — | — | CN | disclosed |
| CN-113260332-A | Photocurable resin composition, photocurable resin product, and method for producing product | 加利福尼亚大学董事会 | 2021-08-13 | — | — | CN | disclosed |
| US-20210238335-A1 | Photocurable Resin Composition, Photocurable Resin Article, and Methods of Fabricating the Article | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION | 2021-08-05 | — | — | US | disclosed |
| WO-2020081891-A1 | PHOTOCURABLE RESIN COMPOSITION, PHOTOCURABLE RESIN ARTICLE, AND METHODS OF FABRICATING THE ARTICLE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-04-23 | — | — | WO | disclosed |
| EP-2750657-B1 | BISUREA GELLING AGENTS AND COMPOSITIONS | MILLIKEN & CO (US) | 2018-03-21 | — | — | EP | disclosed |
| US-6749554-B1 | Medical tools and devices with improved ultrasound visibility | AMERSHAM PLC (GB) | 2004-06-15 | — | — | US | disclosed |
| WO-2003072625-A1 | PHOTOCURABLE RESIN COMPOSITION FOR OPTICAL WAVEGUIDE AND OPTICAL WAVEGUIDE MADE OF THE SAME | LUVANTIX CO., LTD. (KR) | 2003-09-04 | — | — | WO | disclosed |
| EP-0442013-B1 | Isocyanate- and isothiocyanate-modified polysilazane ceramic precursors | LANXIDE TECHNOLOGY CO LTD (US) | 1996-06-05 | — | — | EP | disclosed |
| EP-0442013-A1 | Isocyanate- and isothiocyanate-modified polysilazane ceramic precursors | LANXIDE TECHNOLOGY COMPANY, LP (US) | 1991-08-21 | — | — | EP | disclosed |
| US-5021533-A | Intermediate for silicon nitride ceramics | HERCULES INCORPORATED (US) | 1991-06-04 | — | — | US | disclosed |
| US-5001090-A | Silicon nitride ceramics from isocyanate- and isothiocyanate-modified polysilazanes | HERCULES INCORPORATED (US) | 1991-03-19 | — | — | US | disclosed |
| US-4929704-A | AMMONIA REACTED WITH HALOSILANES, AMMONOLYSIS, WITH ISOCYANATE, ISOTHIOCYANATE | HERCULES INCORPORATED (US) | 1990-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060116290-A1 | Particulate suspensions | PFAS, VCL, JMJD7 | CYP3A4 498/4885TRPA1 4071/4885ALDH1A1 984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.